The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-10
DOI
10.1002/jcb.28342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588
- (2016) Jia Yu Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A phase I study of elesclomol sodium in patients with acute myeloid leukemia
- (2016) David Hedley et al. LEUKEMIA & LYMPHOMA
- Mitochondria and Cancer
- (2016) Wei-Xing Zong et al. MOLECULAR CELL
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
- (2016) Suet-Yan Kwan et al. Oncotarget
- Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)
- (2015) Brian B. Hasinoff et al. BIOCHEMICAL PHARMACOLOGY
- The role of individual caspases in cell death induction by taxanes in breast cancer cells
- (2015) Michael Jelínek et al. Cancer Cell International
- Regulation of Bax/mitochondria interaction by AKT
- (2015) Lilit Simonyan et al. FEBS LETTERS
- Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II)
- (2013) Arun A. Yadav et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
- (2012) Ronald K. Blackman et al. PLoS One
- Mitochondrial Respiration - An Important Therapeutic Target in Melanoma
- (2012) Michelle Barbi de Moura et al. PLoS One
- Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells
- (2009) Ying Qu et al. BREAST CANCER RESEARCH AND TREATMENT
- N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)
- (2009) Medhi Wangpaichitr et al. Cancers
- Mitochondrial drugs
- (2008) Peter L Toogood CURRENT OPINION IN CHEMICAL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started